NIH participates in the
Global Alliance for Chronic Diseases (GACD), a collection of publicly funded research agencies that supports innovative research collaborations to address the prevention and treatment of chronic diseases in vulnerable populations.
View and filter
GACD-supported projects.
Current Funding Opportunities
NCD Multimorbidity Research in LMICs and US Tribal Populations
The current NIH-GACD Funding Opportunity Announcement supports applications that aim to improve the availability of effective, equitable, efficient, integrated, patient-centered, safe, and timely care for people living with multiple long-term conditions (non-communicable disease (NCD) multimorbidity) in low- and middle-income countries (LMICs) and/or within American Indian/Alaska Native (AI/AN) populations in the United States.
NIH funding opportunities supporting this call for applications:
Application due date: The due date for both funding opportunities is
February 7, 2025.
Pre-Application Technical Assistance Webinar
Fogarty will host a pre-application technical assistance webinar to aid potential applicants for the NCD Multimorbidity Research in LMICs and US Tribal Populations (PAR-25-213 and PAR-25-223).
Learn more and register
Previous Funding Opportunities
Topic | Focus |
---|
Noncommunicable Disease (NCD) Prevention in Cities | Implementation research to reduce the risks of NCDs in the context of cities in low- and middle-income countries (LMICs) and among American Indian/Alaska Native (AI/AN) populations in US cities, with the potential to equip policymakers and practitioners with evidence-based strategies for prevention and/or management of NCDs among disadvantaged populations globally.
|
---|
Critical Life Stages | |
---|
Primary and Secondary Prevention of Cancer | |
---|
Scaling-up Evidence-based Interventions | |
---|
Mental Health Research | Child, adolescent and adult age onset mental disorders including, but not limited to, dementia, depression, schizophrenia, bipolar disorders, alcohol- and drug-use disorders, etc., in low- and middle-income countries and/or in vulnerable populations in high-income countries.
|
---|
Lung Disease Research | |
---|
Type 2 Diabetes Research | |
---|
Hypertension Research | |
---|
Related Information & Resources
Related News
Updated October 29, 2024